- Spearheading pivotal GLP and non-GLP toxicity studies in rodents and non-rodents for the development of novel pharmaceuticals in a wide range of indications as well as chemicals under REACH- Team Lead- Contributed to the successful GLP certification and establishment of a fully competent GLP test facility.- Driving 3R and animal welfare.- Prioritizing high quality of scientific data and transparent communication with clients.

Karl-Enigk Research Fellowship and Research Associate- Established a genetic computer model of anthelmintic resistance development (Python)- Screened for novel drug resistance inhibitors using different in vitro assays- Used CRISPR/Cas9 in C. elegans to investigate drug resistance mechanisms- Acquired new research funding to continue the project (DFG)

Institute for Parasitology and Tropical Veterinary Medicine- Coordinated multiple research projects with international collaborators- Responsibility for Veterinary Care and Animal Welfare of laboratory animals in in vivo pharmacological and parasitological research projects- Acquired experience with dogs, cats, sheeps, mice, gerbils, cattle, pigs in animal tests for basic research- Held courses (teaching) and supervised students- Acquired new research funding (e.g. Karl… Show more Institute for Parasitology and Tropical Veterinary Medicine- Coordinated multiple research projects with international collaborators- Responsibility for Veterinary Care and Animal Welfare of laboratory animals in in vivo pharmacological and parasitological research projects- Acquired experience with dogs, cats, sheeps, mice, gerbils, cattle, pigs in animal tests for basic research- Held courses (teaching) and supervised students- Acquired new research funding (e.g. Karl Enigk Fellowship) Show less

DAAD Procope Exchange ProgramUsing CRISPR/Cas9 in Caenorhabditis elegans to decipher anthelmintic drug resistance